calculation of serum hepcidin levels in oral submucous fibrosis.
Not Applicable
Completed
- Conditions
- Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 3: null- Patients with Oral Submucous Fibrosis of Different grades including with dysplasia
- Registration Number
- CTRI/2016/03/006761
- Lead Sponsor
- Rajiv Gandhi University of Health Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Male and female patients with different grades of Oral Submucous Fibrosis including that with dysplastic changes
Exclusion Criteria
Patients who are systemically ill with chronic inflammatory diseases and patients who have laready been treated for OSMF and are on antioxdiant medications
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hepcidin levels with varying degrees of OSMFTimepoint: At baseline that is at the start of the study
- Secondary Outcome Measures
Name Time Method varying levels of hepcidin in OSMF with dysplasiaTimepoint: At the end of 3 months